Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Joseph Kwiatkowski, M.D., Ph.D.

Co-Author

This page shows the publications co-authored by David Kwiatkowski and Katarzyna Klonowska.
Connection Strength

1.733
  1. Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex. J Med Genet. 2021 Oct 11.
    View in: PubMed
    Score: 0.991
  2. Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations. Clin Cancer Res. 2021 Jul 15; 27(14):3845-3853.
    View in: PubMed
    Score: 0.238
  3. TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study. Genet Med. 2020 09; 22(9):1489-1497.
    View in: PubMed
    Score: 0.225
  4. Celecoxib in lymphangioleiomyomatosis: results of a phase I clinical trial. Eur Respir J. 2020 05; 55(5).
    View in: PubMed
    Score: 0.225
  5. Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex. Annu Rev Genomics Hum Genet. 2019 08 31; 20:217-240.
    View in: PubMed
    Score: 0.052
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.